ARCHIVES

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | December 28, 2007

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

July 29, 2005

In Brief: Couple Gives $1.1 Mil. To NCI Intramural Research; Kuller Replaces Grufferman At PCI

February 16, 1990

Centers: Bookman Leaves Fox Chase for Arizona

September 11, 2009

In Brief: Innovative Antismoking Efforts Needed, CCRAC Told, Illinois To Go After Neutron Contract

December 8, 1978

Voluntary Organizations: ACS Board Approves Prostate Cancer Funding Set-Asides

November 15, 1996

FASEB urges 10 percent increase for NIH in FY 2005.

January 23, 2004